Skip to main content
Quest Diagnostics

Extramedullary Intradural Spinal Tumor in an Infant With Neurocutaneous Melanosis

Extramedullary Intradural Spinal Tumor in an Infant With Neurocutaneous Melanosis

Authors: Welch RL, Fluss R, Inocencio J, Fecher R, Dalvi N, Mir A, Baker A, Martin A, Behbahani M

Citation: Pediatr Blood Cancer. 2026 Jun 8:e70372. doi: 10.1002/1545-5017.70372. Online ahead of print.

Specialties: Dermatology, Oncology, Pediatrics

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics

Related content

Publication
Compound Heterozygous Variants in MAPK8IP3 Were Detected in Severe Congenital Hypotonia Mimicking Lethal Spinal Muscular Atrophy
Publication
Evolving approaches to prenatal genetic counseling for Spinal Muscular Atrophy in the new treatment era
Publication
Diagnostic Performance of Artificial Intelligence for Histologic Melanoma Recognition Compared to 18 International Expert Pathologists
Publication
Congenital Melanocytic Nevi Initiated by BRAF Fusion Oncogene With Firmness, Pruritus, and Desmoplastic Stroma

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.